Company / Goodwill
Sana Biotechnology, Inc. Goodwill History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$140.6M
FY2024
5-year range
$140.6M / $140.6M
FY2020-FY2024
Trend
+0.0%
vs FY2023
Sector context
#30 of 74
Health Care
What the data says
At $141M, Sana Biotechnology, Inc.'s goodwill ranks #30 of 74 in the Health Care sector. Goodwill remained relatively stable over the past 5 years, with values between $141M and $141M.
Based on SEC 10-K filings.
$141M in FY2024 with a 3-year CAGR of +0.0%.
Remained stable around $141M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#30 of 74 in Health CareTop 41% of 74This company $140.6M Sector average $4.0B
▼
-96.5% below sector average
Key checks
Key Insights
- 3-year CAGR of +0.0%, indicating consistent growth.
- In FY2024, goodwill increased 0.0% year-over-year.
- Ranks #30 out of 74 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $140.6M | +0.0% |
| FY2023 | $140.6M | +0.0% |
| FY2022 | $140.6M | +0.0% |
| FY2021 | $140.6M | +0.0% |
| FY2020 | $140.6M | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026